Molecular and clinical characterization of 1,577 primary prostate cancer tumors to reveal novel clinical and biological insights into its subtypes.

Authors

Felix Feng

Felix Yi-Chung Feng

Department of Radiation Oncology, University of Michigan Health System, Ann Arbor, MI

Felix Yi-Chung Feng , Scott Tomlins , Mohammed Alshalalfa , Nicholas Erho , Kasra Yousefi , Shuang Zhao , Robert Benjamin Den , Adam Dicker , Edward M. Schaeffer , Eric A. Klein , Cristina Magi-Galluzzi , R. Jeffrey Karnes , Robert B. Jenkins , Bruce J. Trock , Angelo Demarzo , Elai Davicioni

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

General Poster Session A: Prostate Cancer

Track

Prostate Cancer

Sub Track

Prostate Cancer - Localized Disease

Citation

J Clin Oncol 33, 2015 (suppl 7; abstr 9)

DOI

10.1200/jco.2015.33.7_suppl.9

Abstract #

9

Poster Bd #

B1

Abstract Disclosures

Similar Posters

First Author: S. M. Falzarano

Poster

2019 Genitourinary Cancers Symposium

A 17-gene genomic prostate score as a predictor of adverse pathology for men on active surveillance.

A 17-gene genomic prostate score as a predictor of adverse pathology for men on active surveillance.

First Author: Zachary Kornberg

First Author: Jeffrey J. Tosoian

Poster

2019 Genitourinary Cancers Symposium

Molecular and imaging correlates of exceptional pathologic response to neoadjuvant ADT plus enzalutamide.

Molecular and imaging correlates of exceptional pathologic response to neoadjuvant ADT plus enzalutamide.

First Author: Adam G. Sowalsky